lobbying_activities: 2427075

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2427075	7ffacda4-c283-4b91-ab36-b86c1112a0cd	Q1	BROYDRICK & ASSOCIATES	7268	EXELA PHARMA SCIENCES	2020	first_quarter	PHA	Drug shortages and FDA approval. USTR acceptance.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE			0	0	2020-04-15T17:25:25.787000-04:00